Even though several studies have demonstrated that periconceptional supplementation with folic acid (FA) reduces the occurrence of neural tube defects, FA fortification has been a topic of intense debate due to the possible adverse effects of higher folate status on several health conditions. Several countries, including Korea, have been indecisive as to whether fortification is warranted or not. It is therefore helpful for these countries to compare folate concentrations in their populations with populations exposed to mandatory FA fortification. Purpose: To evaluate the differences in the distribution of circulating concentrations of folate in Korea and the United States (US) at different time points. Methods: The Korean study populations consisted of women of child-bearing age recruited in 1999 and in 2009. The US study populations consisted of women of child-bearing age recruited in the post FA fortification era (2005 and 2009). Plasma and red blood cell (RBC) folate concentrations were measured using the Lactobacillus casei microbiological assay. Results: The percentage of US women with neural tube defect-protective levels of RBC folate was significantly higher compared to Korean women in 1999. However, in 2009, when FA supplements became readily available for Koreans, 50% of Korean women in the study achieved the neural tube defect-protective level of RBC folate; 11% of them demonstrating supraphysiologic concentrations of plasma folate. Even though FA fortification in the US resulted in more than 80% of women achieving .400 ng/mL of RBC folate by 2009, nearly 50% also demonstrated having supraphysiologic concentrations of plasma folate, which prompted some researchers to raise concerns about possible adverse effects of higher folate status on several health conditions. Conclusion: Encouraging Korean women of reproductive age to take FA supplements and evaluating the outcome of such efforts would be worthwhile prior to implementing a populationwide mandatory FA fortification in Korea.
Introduction
Folate, a water soluble B vitamin occurring naturally in fruits and vegetables, is involved in various cellular activities as a methyl donor for methylation reactions. Because of its pivotal role in cellular metabolism, folate status has been linked with several health outcomes. Several observational studies and intervention trials have demonstrated that periconceptional supplementation with folic acid (FA), a synthetic form of folate, reduces the occurrence of birth defects, especially neural tube defects (NTDs). 1, 2 However, in general, public health campaigns have failed to improve folate status through recommendations of FA supplements as demonstrated by a low proportion of women of child-bearing age consuming FA supplements periconceptionally and nearly half of this population having unplanned pregnancies. 3 Fortification of foods with FA thus offered a plausible solution to these failed health campaigns, and in 1998 fortification of cereal grains with FA (140 µg/100 g of flour) was mandated by the United States (US) Food and Drug Administration, with the main purpose of reducing the risk of NTDs by increasing folate intake in women of child-bearing age. 4 Simultaneously, countries like Canada and Chile implemented mandatory FA fortification of flour. Today, nearly 60 countries have implemented the mandatory FA fortification of food, not only to reduce the prevalence of NTDs but also to possibly reduce folate deficiency associated with other poor health outcomes. 5 Despite the growing list of countries that are fortifying flour with FA, and that the adverse effects associated with FA are most likely due to extra supplement use and not due to mandatory fortification, 6 there are several countries -including Korea -that are in a dilemma due to the ensuing debate on the safety of population-wide exposure to higher levels of folate on health conditions other than NTDs; there is also the belief that folate intake among women is adequate and that individuals have the right not to consume supplemental FA if they so choose to do so. 7, 8 Since the initiation of FA fortification, National Health and Nutrition Examination Surveys in the US have documented a 1.5-3-fold increase in the circulating concentrations of folate. This has resulted in an 80%-90% decline in the prevalence rate of lower circulating concentrations of folate (#3 ng/mL of serum folate and #140 ng/mL for red blood cell [RBC] folate), particularly among women of child-bearing age, from 1988-2006 and a 19%-27% reduction in the prevalence of NTDs. [9] [10] [11] Although the program was able to achieve its intended objective of reducing the prevalence of NTDs, the FA fortification program has been under scrutiny with regard to potential adverse effects of higher concentrations of folate on many disease conditions. Approximately 23% of the US population has been reported to have circulating concentrations of folate .19.8 ng/mL (referred to as supraphysiologic concentrations) within 2 years of exposure to the FA fortification program. 12 Higher circulating concentrations of folate have been hypothesized to mask pernicious anemia due to vitamin B12 deficiency, cause cognitive impairment in elderly subjects, reduce the efficacy of antifolate drugs used in the treatment of malaria, rheumatoid arthritis, and psoriasis, and -most importantly -to exert adverse effects on immune function and have the potential to promote cancer. [13] [14] [15] [16] Further, there have been several reports associating excess body weight with folate concentrations. 17, 18 Another report showed that after mandatory FA fortification, higher maternal weight was associated with increased risk of NTDs. 19 Population-wide changes in folate intake may occur in the absence of FA fortification due to changes in dietary habits or the availability of supplements containing FA. Therefore, evaluation of these trends and a comparison of individuals exposed to FA fortification programs will be informative in making decisions regarding fortification of commonly used food items with FA. The authors were in a unique position to carry out a comparison of this nature due to (1) the availability of data on circulating concentrations of folate in Korean women of child-bearing age during a time period when FA supplements were rarely available, ie, 1999, 20 and when FA supplements were readily available, ie, 2009; 21 and (2) the availability of folate data from a US population exposed to an FA fortification program. With this background, the main purpose of the current study was to evaluate differences in the distribution of folate concentrations in women of child-bearing age of similar age range in the US and Korea at different time points. Because the prevalence of obesity differs between Korea and US, and a likely association between obesity and folate status has been reported, another purpose of the study was to exclude the possibility that the differences in folate concentrations that were observed were due to the differences in the prevalence of obesity between the two countries.
Methods

Study population
The study populations consisted of women of child-bearing age from Korea and the US who had largely a sedentary lifestyle ( Table 1 ). The Korean study populations consisted of students from Chungbuk National University ( Cheongju, Korea) enrolled during the year 1999 (n = 52) and 2009 (n = 90). The US study populations were a subset of 338 women enrolled in 2005 by a study funded by the National Cancer Institute (R01 CA105448) and a subset of 146 women enrolled by another study funded by National Cancer Institute in 2009 (R01 CA102489). All women enrolled in the US studies were diagnosed with an abnormal Pap smear but were free of biopsy-confirmed higher grade cervical intraepithelial neoplasia. Women in the Korean study were between the age range of 18-26 years who were likely to be sexually active but with unknown Pap diagnoses. In order to allow a comparison of plasma folate and RBC folate data between the study populations independent of submit your manuscript | www.dovepress.com 24, 25 and in the US post FA fortification era. 9 The study protocols were approved by the respective Institutional Review Boards.
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Laboratory methods
In all study populations, fasting blood samples were collected using standard protocols, ie, a 10 mL sample was drawn from each subject into ethylenediaminetetraacetic acid-containing evacuated tubes. Plasma and RBC folate concentrations in all study populations were determined following L. casei microbiological assay protocols established in the Department of Nutrition Sciences at the University of Alabama at Birmingham (Birmingham, AL). 26 The L. casei microorganism was obtained from the American Type Culture Collection (7469; Rockville, MD). FA purified by butanol extraction was used as the folate calibrator in the assay. A 96-well plate adaptation of the assay was used to measure folate. To monitor the reproducibility of the assay, two pooled samples (low and high) prepared from plasma and obtained from the American Red Cross were assayed for folate concentrations at least 30 times in order to establish the mean ± standard deviation. This served as the basis for the quality control for the assay as determined by the Westgard "multirule" procedure. The low and high control pools were included in every plate.
The coefficient of variation of the folate microbiological assay in both laboratories (US and Korean) was ,10%. All samples were stored at −80°C until the measurements were completed within 3 months of sample collection.
Anthropometric measurements
Height and weight were obtained using standard protocols. The body mass index (BMI) was calculated using the height and weight measurements (kg/m 2 ).
Statistical methods
Descriptive statistics were used to describe the study population. Differences in the BMI and circulating concentrations of folate in the study populations were tested using the median test. Differences in the distribution of women based on the plasma folate categories (#3 ng/mL, .3-10 ng/mL, .10-19.8 ng/mL, and .19.8 ng/mL) and RBC folate categories (#140, .140-400 ng/mL, and .400 ng/mL) were determined using Pearson's chi-squared test. In order to rule out the possibility that the differences in BMI may explain the differences in the distribution of the circulating concentration of folate, differences in the median plasma and RBC folate concentrations were evaluated using the median test in the Korean study populations and a subset of the US population with a BMI range similar to that of the Korean population (17-32 kg/m 2 ). All analyses were performed in JMP ® version 9.0 (SAS Institute, Cary, NC), and were considered significant at P , 0.05.
Results
The study population consisted of women in three ethnic groups: Koreans, US AAs, and US CAs. AA women in both US studies had a higher median BMI followed by CA Table 1) .
The populations were then categorized based on the following plasma folate categories: #3 ng/mL (deficient), .3-10 ng/mL (sufficient), .10-19.8 ng/mL (higher), and .19.8 ng/mL (supraphysiologic). As shown in Table 2 , none of the study populations had plasma folate concentrations #3 ng/mL. Statistically significant differences were observed in the distribution of Korean women in 1999 and 2009 in the different categories of plasma folate concentrations (Table 2) . While 83% and 17% of the Korean women in 1999 had plasma folate concentrations of .3-10 ng/mL and .10-19.8 ng/mL, respectively, 42% and 47% of women had plasma folate concentrations of . With regard to RBC folate concentrations, the women were categorized based on the recommended concentrations of RBC folate required to reduce the risk of NTDs: #140 ng/mL (deficient), .140-400 ng/mL (low), and .400 ng/mL (sufficient). Only 2% of Korean women had deficient RBC folate concentrations in 1999. None of the other populations included in this study had deficient levels of RBC folate. Statistically significant differences were observed in the distribution of Korean women in 1999 and 2009 by RBC folate categories (Table 2) . Compared to 27% of Korean women in 1999, 50% had folate concentrations .400 ng/mL in 2009. Wide differences were also observed between RBC folate concentrations in Korean women in 1999 and AA and CA women in 2005. In contrast to 27% of Korean women, 79% of AA and 92% of CA women had RBC folate concentrations .400 ng/mL. Further, there were significant differences in the RBC folate distribution between Korean women in 2009 and AA and CA women in 2005. While only 50% of Korean women had RBC folate concentrations .400 ng/mL, 79% of AA and 92% of CA women had RBC folate concentrations .400 ng/mL. Significant differences were also observed between Korean women in 1999 and 2009 and AA and CA women in 2009. As reported in previous studies, racial differences were observed in the current study in the distribution of folate concentrations between CA and AA women, with a higher percentage of CAs having supraphysiologic concentrations of plasma folate and recommended concentrations of RBC folate compared to AAs. 22, 23 As shown in Table 3 , it was observed that there was significant variation in the folate concentrations in women by ethnicity and by the year of sample collection within the group of Korean and US women with a BMI range of 17-32 kg/m 2 , similar to the results observed with the entire group (Table 1) . 
Discussion
Several epidemiological studies have shown that an intake of 400 µg FA per day before pregnancy and during the early weeks of gestation is associated with a reduction in NTDs. 27, 28 An evaluation of the relationship between the risk of NTD and maternal concentrations of RBC folate have shown that the lowest category of NTD risk occurred when maternal RBC folate concentrations were .400 ng/mL, 29 suggesting that achieving this level of RBC folate should be the goal for individual recommendations or population-wide FA fortification programs. Many believe that achieving this protective folate concentration by dietary means alone remains a challenge among women of child-bearing age. As expected, the percentage of US women with an NTD-protective level of RBC folate was significantly higher since 2005 compared to Korean women in 1999 or 2009 and these differences were independent of the differences in BMI between Korean and US women. The present study also demonstrated that although none of the Korean women had deficient plasma folate concentrations (#3 ng/mL) in 1999, 73% of them had RBC folate concentrations below the level thought to be protective against NTDs when FA supplements were not recommended in Korea for nonpregnant women and when multivitamin supplements rarely contained FA. In 2009, when FA supplements became readily available for women of child-bearing age in Korea, 50% of women achieved the NTD-protective level of RBC folate along with 11% of women demonstrating supraphysiologic concentrations of plasma folate, similar to the percentage of US AA women (8%) exposed to mandatory FA fortification in 2005, but likely with lower FA supplement intake. 30 Even though FA fortification in the US resulted in more than 80% of women achieving .400 ng/mL of RBC folate by 2009, nearly 50% of US CA women by then also demonstrated supraphysiologic concentrations of plasma folate (.45 nmol/L or .19.8 ng/mL), a level which prompted some researchers to raise concerns about possible adverse effects of higher folate status on several health conditions, as stated in the introduction. Supraphysiologic folate concentrations are likely to be associated with the presence of unmetabolized FA. 31 Evidence suggests that unmetabolized FA found in blood after the ingestion of supplements or fortified foods may have adverse effects on folate binding proteins or transporters, 32 possibly interfering with normal folate metabolism. Although it is possible that unmetabolized FA may have different effects on already initiated cancer cells compared to uninitiated cells, it is also important to understand that fortification will not only raise the concentrations of unmetabolized FA but also the concentrations of total folate in the body, which could have disease protective effects. The studies in the US did not corroborate the concern that supraphysiologic plasma folate concentrations seen in the post US FA fortification era increase the risk of precancerous lesions in the cervix in premenopausal women of child-bearing age. In fact, higher folate was associated with significantly lower risk of those lesions, especially when vitamin B12 is sufficient, demonstrating the importance of vitamin B12 in the high folate environment created by the FA fortification program. 33 Because adequate numbers of women who had supraphysiologic concentrations of plasma folate and insufficient vitamin B12 were not found, it was not possible to evaluate whether cervical cancer risk may be higher in women with such a combination. The rarity of this micronutrient profile in this group of US women at higher risk of developing cervical cancer suggests that this concern may be of little public health relevance. However, studies have documented conflicting or equivocal results for the role of folate in other cancers, including neuroblastoma, 34 breast cancer, 35 and colorectal cancer. 36 This inability to reach a consensus represents a critical issue and deserves further studies in view of the FA fortification programs that are underway in many countries, potentially exposing billions of people to higher levels of FA.
A study conducted in Korea in 2006-2007 demonstrated that serum folate concentrations were inversely associated with the risk of cervical cancer. 24 The range of serum folate concentrations in the control group of this study (ie, females who had a normal Pap smear on the day of recruitment without any history of abnormal Pap smears) was 8.2-17.5 ng/mL, 25 which is higher than the mean plasma folate concentrations of Korean women in 1999 (7.5 ng/mL) and lower than the plasma folate concentrations of Korean women in 2009 (12.5 ng/mL) from the current study, indicating a trend of increasing plasma folate concentrations. Newer studies are needed in Korea to answer whether the folate concentrations continue to increase and evaluate the effects of current folate concentrations on cancer risk (cervical and other cancers) and also to establish the proportion of women exceeding supraphysiologic concentrations of serum folate. This is an important issue since exposure to higher levels of folate during pregnancy is now thought to exert adverse effects on the offspring. For example, higher periconceptional FA intake was shown to be associated with increased risk of multiple congenital abnormalities, 37, 38 asthma, 39 atopic dermatitis, 40 and a possible increase in the prevalence of autism and other related autism spectrum disorders, including Asperger disorder, childhood degenerative disorder, and pervasive developmental disorder not otherwise specified.
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Conclusion
According to the current study, in the absence of a mandatory FA fortification program, 50% of Korean women have RBC levels which may be protective for NTDs. Therefore, even though public health campaigns have failed to improve folate status through recommendations of FA supplements in other countries, encouraging reproductive age Korean women to take FA supplements and evaluating the outcome of such efforts would be worthwhile prior to implementing a population wide mandatory FA fortification in Korea. Since a substantial increase in folate levels was observed during a 10-year period, careful monitoring of folate levels and assessment of the reasons for increases in folate levels other than the availability of FA supplements will be required to avoid Korean women from reaching supraphysiologic concentrations of folate, especially if Korea decides to implement an FA fortification program. Because of the well-described limitations in the food composition tables in Korea, 7 no attempt was made to compare folate intake levels between US and Korean women. Careful evaluation of folate status of Korean women of child-bearing age using improved food composition tables is warranted in future studies to establish the folate status in this population. It may also be necessary to monitor vitamin B12 levels since an imbalance created between the two micronutrients (higher folate and lower vitamin B12) during pregnancy has been associated with intrauterine programming predisposing to a common metabolic disorder seen worldwide, namely, insulin resistance. 42 Finally, Koreans are unlikely to be as racially diverse as in the US, but regional differences in dietary habits or supplement use may contribute to differences in folate/vitamin B12 status, indicating the need for assessment of folate and vitamin B12 in a nationally representative sample of Korean women.
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